Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Oct 5:2021:1622533.
doi: 10.1155/2021/1622533. eCollection 2021.

Abnormal Liver Tests during Hospitalization Predict Mortality in Patients with COVID-19: A Multicenter Study from South America

Domingo Balderramo  1 , Angelo Z Mattos  2   3 , Victoria Mulqui  1   4 , Talita Chiesa  3 , Zuly Plácido-Damián  5 , Jaysoom Abarca  6 , Andrea Bolomo  1 , Yanina Carlino  1 , Isadora Z Bombassaro  3 , Denusa Wiltgen  2   7 , Laura Tenorio Castillo  5 , Karina Díaz  6 , Johana Acuña  6 , Estela Manero  4 , Jhon Prieto  8 , Enrique Carrera  6 , Javier Díaz-Ferrer  5 , Jose D Debes  9
Affiliations
Multicenter Study

Abnormal Liver Tests during Hospitalization Predict Mortality in Patients with COVID-19: A Multicenter Study from South America

Domingo Balderramo et al. Can J Gastroenterol Hepatol. .

Abstract

Background: The role of liver function tests (LFT) as prognostic factors in patients admitted with COVID-19 has not been fully investigated, particularly outside resource-rich countries. We aimed at evaluating the prognostic value of abnormal LFT on admission and during hospitalization of patients with COVID-19.

Methods: We performed a retrospective study that included 298 adult patients hospitalized for COVID-19, between 05/2020 and 02/2021, in 6 hospitals from 5 countries in South America. We analyzed demographic and comorbid variables and laboratory tests on admission and during hospitalization. LFT over twice the upper limit of normal (ALEx2) were also evaluated in relation to a variety of factors on admission and during hospitalization. De novo-ALEx2 was defined as the presence of ALEx2 at one week of hospitalization in patients without ALEx2 on admission. Patients were followed until hospital discharge or death. Multivariable analysis was used to evaluate the association between ALEx2 on admission and during hospitalization and mortality.

Results: Of the total of 298 patients, 60% were male, with a mean age of 60 years, and 74% of patients had at least one comorbidity. Of those, 137 (46%) patients were transferred to the intensive care unit and 66 (22.1%) patients died during hospitalization. ALEx2 on admission was present in 87 (29.2%) patients and was found to be independently associated with 1-week mortality (odds ratio (OR) = 3.55; 95% confidence interval (95%CI) 1.05-12.05). Moreover, 84 (39.8%) out of 211 patients without ALEx2 at admission developed de novo-ALEx2, which was independently associated with mortality during second week of hospitalization (OR = 6.09; 95%CI 1.28-29) and overall mortality (OR = 2.93, 95%CI 1.05-8.19).

Conclusions: A moderate elevation of LFT during admission was associated with a poor short-term prognosis in patients hospitalized with COVID-19. In addition, moderate elevation of LFT at one week of hospitalization was an independent risk factor for overall mortality in these patients.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet . 2020;395(10229):1054–1062. doi: 10.1016/s0140-6736(20)30566-3. - DOI - PMC - PubMed
    1. Richardson S., Hirsch J. S., Narasimhan M., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. Journal of the American Medical Association . 2020;323(20):2052–2059. doi: 10.1001/jama.2020.6775. - DOI - PMC - PubMed
    1. Schönfeld D., Arias S., Bossio J. C., Fernández H., Gozal D., Pérez-Chada D. Clinical presentation and outcomes of the first patients with COVID-19 in Argentina: results of 207079 cases from a national database. PloS One . 2021;16(2) doi: 10.1371/journal.pone.0246793.e0246793 - DOI - PMC - PubMed
    1. Olivas-Martínez A., Cárdenas-Fragoso J. L., Jiménez J. V., et al. In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation. PloS One . 2021;16(2) doi: 10.1371/journal.pone.0245772.e0245772 - DOI - PMC - PubMed
    1. Wu C., Chen X., Cai Y., et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Internal Medicine . 2020;180(7):934–943. doi: 10.1001/jamainternmed.2020.0994. - DOI - PMC - PubMed

Publication types